专利信息

查询条件展开筛选条件

[IPC] 包含 'A'

[专利权人] 包含 'H. Lundbeck A/s'

首页 1 2 3 4 5 6 下页尾页共 797 条记录, 当前第1/80页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 6 下页尾页共 797 条记录, 当前第1/80页。

当前查询条件: [IPC] 包含 'A' AND [专利权人] 包含 'H. Lundbeck A/s'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US8664225B2	2014/3/4
专利标题：1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition 专利权人：H. Lundbeck A/s; The use of 1-[2-(24-dimethylphenylsulfanyl)phenyl]piperazine in the treatment of pain and residual symptoms in depression is provided.

2. US20130217776A1	2013/8/22	US13/552699	2012/7/19
专利标题：Combination of a serotonin reuptake inhibitor and agomelatine 专利权人：H. Lundbeck A/s; The present invention relates to the use of a combination of agomelatine and a serotonin reuptake inhibitor (SRIs) or any other compound which causes an elevation in the level of extracellular serotonin for the treatment of depression and other affective disorders.

3. EP2470166B1	2013/8/14
专利标题：New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine 专利权人：H. Lundbeck A/s;

4. US20130184291A1	2013/7/18
专利标题：Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsuflanyl)phenyl]piperazine 专利权人：H. Lundbeck A/s; The invention provides new therapeutic uses of 1-[2-(24-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

5. US8476279B2	2013/7/2
专利标题：Phenyl-piperazine derivatives as serotonin reuptake inhibitors 专利权人：H. Lundbeck A/s; The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder including depression anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.

6. TW201315469A	2013/4/16
专利标题：New positive allosteric modulators of nicotinic acetylcholine receptor 专利权人：H. Lundbeck A/s; The present invention relates to compounds useful in therapy to compositions comprising said compounds and to methods of treating diseases comprising administration of said compounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine 7 receptor.

7. AU2010238946B2	2013/3/28
专利标题：Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl] piperazine 专利权人：H. Lundbeck A/s; Liquid formulations of lactic acid addition salts of l-[2-(24-dimethylphenylsulfanyl)- phenyljpiperazine are provided.

8. AU2010289022B2	2013/3/14
专利标题：New compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine 专利权人：H. Lundbeck A/s; Pharmaceutical compositions of 1-[2-(24-dimethyl-phenylsulfanyl)- phenyl]piperazine and pharmaceutically acceptable acid addition salts thereof adapted so that release does not take place in the stomach is provided.

9. US20130012530A1	2013/1/10
专利标题：New positive allosteric modulators of nicotinic acetylcholine receptor 专利权人：H. Lundbeck A/s; The present invention relates to compounds useful in therapy to compositions comprising said compounds and to methods of treating diseases comprising administration of said compounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.

10. US20130005743A1	2013/1/3
专利标题：New positive allosteric modulators of nicotinic acetylcholine receptor 专利权人：H. Lundbeck A/s; The present invention relates to compounds useful in therapy to compositions comprising said compounds and to methods of treating diseases comprising administration of said compounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.

下载范围

下载内容